"Transavia Airlines extends Q-Pulse safety system for risk and flight data monitoring
15 January 2018
The Dutch airlines software upgrade to the latest version of Ideagens Q-Pulse system will simplify reporting to ECCAIRS
Transavia Airlines, the Dutch low cost airline, is to expand its software system from Ideagen in a move that will enhance risk management and flight safety reporting.
The airline, which has been in operation for over 50 years, will upgrade its Q-Pulse system, adding Ideagens Q-Pulse Risk while integrating with Aerobytes Flight Data Monitoring (FDM) system.
The software upgrade will allow Transavia crew to easily complete and submit safety reports, such as ECCAIRS, required for Transavias European legislation requirements including those of the European Aviation Safety Agency (EASA).
The addition of risk and FDM will boost Transavias risk visibility, allowing them to quickly spot potential weakness through the BowTie methodology for risk management. FDM integration will enable safety staff to assess individual flights, providing increased visibility of operational and safety data.
Maikel van den Ham, Safety Engineer at Transavia Airlines, said: With this software upgrade, and the additions of Q-Pulse Risk and FDM integration, we will be provided with a better view of what is happening in terms of safety and risk management within the airline.
By gaining as much data as possible from across the business, including from each flight thanks to the FDM addition, we will be able to spot and act earlier on any trends that emerge.
Maikel added: By making the ECCAIRS reporting process simpler, we will be able to meet the requirements of EASA and our national legislator more easily.
Transavia Airlines has been operating for over 50 years having been established in 1965. Launched in the Netherlands, the airline also has a base in France and also flies from more than 20 countries in Europe and the Mediterranean. The airline is currently part of the AIR FRANCE KLM Group, the largest aviation group in Europe.
Ideagen is the leading global provider of aviation safety management and reporting solutions. Currently, more than 300 aviation organisations including over 100 airlines use its products and services globally.
Clients in the aviation space include the likes of Emirates, Ryanair, flybe, Brussels Airlines, Air Asia and Spirit Airlines as well as the International Airlines Group - owners of British Airways, Vueling, Iberia and Aer Lingus."
Nice to see but these NHS contracts are small fry, I am waiting for the game-changing $5m contracts to arrive, perhaps from the U.S. Thats what will really move things ahead!
Results should be out in next week or so, looking forward to that.
Ideagen logoKings Interventional Facilities Management (IFM) is working with AIM-listed Ideagen to deploy its Q-Pulse quality, compliance safety and operational risk management platform. Kings IFM is a Limited Liability Partnership controlled by the Kings College Hospital NHS Foundation Trust. It provides fully managed services across all sites within the Trust, including Kings College Hospital, Princess Royal University Hospital and Orpington Hospital.
Kings IFM aims to use Q-Pulse to centralise and standardise document control giving staff access to policies and Standard Operating Procedures from a single location. Kings College Hospital is already using Q-Pulse in areas such as Haematology and Cancer Services to help ensure compliance with ISO 9001 quality management standards. In the future, it also plans to use Q-Pulse to support the reduction of risk and adverse incidents.
Things appear to be progressing well for the Ideagen; its H1 trading update in November revealed that revenue and adjusted EBITDA were expected to be significantly ahead of H1 FY16, and underlying organic revenue was up c.12%. UK healthcare remains a significant part of its business, where, across all products and services, it currently supplies 75% of NHS Trusts. Budgets remain under tremendous pressure in the NHS as the population ages and demands on the service increase, but the need for greater efficiency in the sector will create further opportunities for Ideagen."
"Kings Interventional Facilities Management, part of Kings College Hospital, roll out Q-Pulse to drive quality improvements
08 January 2018
Ideagens Q-Pulse to support a move to a "robust system of operational compliance
Kings Interventional Facilities Management (IFM) is working with Ideagen to roll-out its Quality Management System, Q-Pulse.
The aim of the implementation is to centralise and standardise document control through the provision of a single location for all staff to access policies and Standard Operating Procedures (SOPs).
Kings IFM is a Limited Liability Partnership controlled by Kings College Hospital NHS Foundation Trust (KCH) and provides fully managed services including procurement, equipment and the supply chain for diagnostic and treatment facilities for the Trust.
It operates across all sites within the Trust, including Kings College Hospital, Princess Royal University Hospital and Orpington Hospital, with an annual turnover of circa £70 million and in excess of 150 staff. In addition, the IFM manages the procurement of an additional circa £300m of annual spend for the Trust.
"05 January 2018
Digitalisation & Industry 4.0 in Manufacturing
By Hannah Waugh
Manufacturers are experiencing a period of drastic change as digital transformation rises throughout the sector as part of what is called Industry 4.0 or the Forth Industrial Revolution.
This digitalisation trend adds pressures to traditional businesses, but also offers exceptional opportunities that will optimise production and increase efficiency. These changes revolutionise activities, processes, competencies and models through a mix of digital technologies with an accelerating impact across not only businesses, but across society and cultures.
Sparked by a shift in new demands from customers, Industry 4.0 is the name for the current trend of automation and new technologies in the manufacturing sector. The revolution brings changes in all areas of life and existing business models. For example, is it just me who has Amazons Echo Dot - Alexa - carry out mundane tasks such as turning on music or making phone calls out of sheer laziness and convenience? This is an example of the shift and a starting point for automisation and its effect on society and the way we all operate.
At a guess £500 to £1000 per user as a once off fee followed. By annual fees of maybe 20% of that figure. Maybe I did a good deal when buying it, maybe Commerzbank will have done an even better deal, difficult to say. On top of these figures there would be fees for training, installation, customisation etc, which may well double the initial contract value, but not the ongoing revenue. Do your own research, and my figures may well be very out of date.
Today IDEA stands at 200% of the price I paid. A most impressive run and I have no intention of taking profits because the management appears to have developed an excellent and timely product in the current age of MIFID II and huge compliance penalties. Thanks to my broker who recommended the stock.
"Ideagen to provide Commerzbank with internal audit software
04 January 2018
Commerzbank, a leading German international commercial bank with branches and offices in almost 50 countries, is to implement Pentana Audit , a software solution from Ideagen, for its global internal audit operations. Pentana Audit is Ideagens risk-based audit automation software solution used by over 450 organisations worldwide.
Commerzbank serves more than 18 million private and small business customers, as well as more than 60,000 corporate customers, multinationals, financial services providers and institutional clients. In 2016, it generated gross revenues of 9.4 billion Euros and employs almost 50,000 staff.
Ideagen specialises in providing compliance, audit, control and risk management solutions to banks, accountancy firms and financial services organisations and works with some of the worlds largest organisations in this area including BDO, BBVA and the European Central Bank.
Its Pentana Assurance suite of software which includes Pentana Audit, Pentana Performance and Pentana Disclose consolidates Ideagens efforts in creating a functionally complete and market leading internal audit, compliance and oversight software suite.
Colin Smith, Ideagens Head of Banking, Finance and Audit at Ideagen, said: This particular project is proof of our standing as one of the leading software providers to the global banking, audit and finance industry.
"WestRocks Multi Packaging Solutions adopts Ideagens Q-Pulse for quality management at all its global sites
19 December 2017
Ideagens software to be rolled out into Europe, North America and China
Multi Packaging Solutions, (MPS), a business of WestRock Company and a leader in value-added print and packaging solutions for the healthcare, branded consumer and multi-media markets, is investing in advanced software from Ideagen as it aims to standardise its quality management processes across all its 70 global sites.
Ideagen Q-Pulse will be rolled out across MPSs healthcare packaging operations in North America and Europe in the initial phase of the project. In phase II, the Q-Pulse software will be extended to the companys global branded packaging operations including several locations in China.
Denise Loughlin, Vice President Quality for Europe at MPS, said: The project with Ideagen will reinforce MPSs position as a truly global supply chain partner for its customers. The nature of our work means that we are a strategic partner to some of the leading pharmaceutical and healthcare organisations in the world. That can also be said for some of the largest consumer brands in the confectionery and spirits sectors across the globe.
The Q-Pulse system will support MPSs goal to offer its customers world class manufacturing quality standards. The software complements recent substantial investment in new printing presses and other ancillary equipment across the business.
"Labcold works with Ideagen to centralise quality & corrective action management
07 December 2017
Labcold, the UK medical refrigeration organisation, will work with Ideagen to centralise its quality management systems solidifying corrective action management and customer feedback.
The Basingstoke-based company, which was the first blood bank refrigeration manufacturer in the UK to gain a medical device certification, is to implement Ideagens Q-Pulse software across its UK operations.
Q-Pulse will help to modernise and centralise the management of Labcolds existing ISO 9001, 13485 and 17025 quality systems.
As well as improvements to both the raising of corrective actions and the management of customer feedback, Q-Pulse will enable Labcold to align inspections and standardise document control.
Michelle Rogers, Sales and Marketing Director, who is overseeing the Q-Pulse project at Labcold, said Q-Pulse will bring with it peace of mind in regards to quality management.
"Aggreko chooses Q-Pulse from Ideagen to manage its global supply chain
29 November 2017
The worlds leading provider of mobile, modular power and heating and cooling has purchased Ideagens flagship Q-Pulse software to manage its global supplier base in 200 locations around the world.
Aggreko expects Q-Pulse to help further improve its processes, including saving time and costs for Aggrekos customers in more than 100 countries.
A company of our size, and with our global reach, needs a state of the art supplier management system, said Martin Dolan, Aggrekos Global Head of Supplier Quality and Development.
Q-Pulse provides us with a central quality management system that will allow us to control the quality, performance and development of our suppliers.
We have offices, depots and service centres in more than 200 locations, so being able to manage our equipment efficiently in all those places helps us to bring our services to customers even more effectively, quicker and cost efficiently than ever.
Aggreko supplies mobile, modular power generation and heating and cooling equipment and services to a broad range of industries, including oil and gas, petrochemical and refining, events, manufacturing, utilities, construction and food and beverage, among others.
The Q-Pulse project will see the software implemented at operational hubs based on each major continent with a new global procurement team managing each region from their respective hubs.
Q-Pulse software will enable around 200 supplier surveillance audits per year. Aggreko will carry out regular calibration and asset maintenance assessments of equipment currently in use by its suppliers. Live data from the system will also enable Aggreko management to assess trends and potential risks from across the business quickly and efficiently.
This is a huge project for us, so we need the correct systems and tools in place. We strongly believe that Q-Pulse is that tool. Were excited to work with Ideagen and Q-Pulse. Our key processes are scheduled to be up and running globally by the end of 2017, so we expect to see immediate benefits and a quick return on our investment, said Martin.
The power to have live data globally will allow us to instantly act on emerging trends. Q-Pulse will help us to be more risk-averse in our approach to how we manage data. It will present us with live data from our manufacturing processes, highlight trends within that data and that will help us identify potential issues before they develop into more serious operational problems.
Ideagen Q-Pulse is used by hundreds of power generation organisations globally. AMong Ideagen's clients in this sector include Scottish Power Generation, Calor Gas, Sabic, Proserv, Fugro and Abu Dhabi Gas Industries."
At days' end hitting high of 95p last seen in June . Decent volume building , supported by steady flow of notification of contract awards assisted by the excellent reporting by Gretel makes the break out more likely than not .
Finncap retain their Buy and 108p target price, and note:
"The contract for delivery of the Q-Pulse quality management system again shows the scale of opportunity for the Ideagen software portfolio, across multiple sectors and territories, and with customers of significant calibre â with a beachhead contract potentially offering further inroads into additional territories for the same global customer.
Following the 7th November trading update reporting performance in line with expectations, Ideagen's momentum remains strong, with an attractive free cash flow yield into FY19 and continuing upside to achieve the Megabuyte accounting and enterprise software peer group index rating of 25x P/E into FY18 and FY19."
For the record, here's what Finncap had to say last week in reiterating their 108p target:
"Interim trading update
Ideagen has announced a trading update highlighting performance in line with unchanged expectations £ implying the company remains on track for 40% EBITDA growth, from total revenue growth of 29%. Organic growth reported at 12% remains comfortably in line with our forecasts, with the acquisitions of Covalent and IPI contributing for their first full year. Cash generation was strong, with net cash of £5.9m at 31 October (vs £4.2m at year end) demonstrating a robust balance sheet and showing our year end net cash of £7.0m to be highly achievable. We reiterate our 108p target, with the current FY19 free cash flow yield of 4.7% evidently too cheap from such growth and execution."
"Ideagens oldest aviation client, Loganair, extends its Q-Pulse system
21 November 2017
Loganair chooses Q-Pulse Risk for its corporate risk management programme
Loganair, the Scottish regional airline, is to adopt risk management software from Ideagen for the management of its corporate and aviation risks.
The Glasgow Airport-based airline, which serves over 40 routes in the United Kingdom, Republic of Ireland and Norway, will implement Q-Pulse Risk in an extension of its existing Q-Pulse system.
Loganair is Ideagens oldest customer in the aviation sector having used the companys Q-Pulse quality and compliance management software for over two decades.
The airline will adopt Q-Pulse Risk to systemically manage key risks including business risks to financial sustainability, efficiency, and customer service.
Scott Peterson, Loganairs Risk and Controls Manager, said: What attracted me to Q-Pulse Risk was the fact that it is aligned with the BowTie risk management methodology, which I consider a best practice in regard to risk management.
Our number one priority is safety risk. However, there are a number of other risks that can be important.
We need to be fully aware of all risks that could impact safety, customer service, efficiency, or financial sustainability for example. The Q-Pulse risk tool will help us identify, analyse, monitor, and provide assurances for all key risks impacting our business.
"RATP Dev North Americas drive2zero program to use Ideagen Coruson for Safety and Incident Management
09 November 2017
The global transportation leader will implement Ideagens cloud-based software as a key part of its new drive2zero safety management framework
Ideagen, developers of quality, safety, audit, risk and performance management software, today announced that RATP Dev North America will integrate Ideagen Coruson software into the public transit leaders new flagship drive2zero safety and security framework.
Coruson, which is a cloud-based software system for enterprise safety, quality, reporting and incident management, will be used by RATP Dev North America to directly manage safety, risk and operational performance across all bus, paratransit and rail services.
Mike Anderson, Vice President of Safety & Security for RATP Dev America, said: drive2zero is RATP Dev North Americas program to enhance our safety management systems. We will achieve drive2zero goals by managing safety and security analysis.
drive2zero has four components - Safety Policy, Risk Management, Safety Assurance and Safety Promotion - to realise continuous improvements to transit operations and support RATP Dev North Americas commitment to an unparalleled safety record for our customers and employees. This approach is the heart of our safety culture.
And secondly, IDEA have won a contract with Worcester City Council:
"Ideagens Pentana Performance software boosts Worcester City Councils transformation programme
13 November 2017
Ideagens software will help the council drive for excellence with enhanced performance monitoring and reporting
Worcester City Council, which provides essential services to over 95,000 residents, is to adopt software from Ideagen as it looks to set up a reporting and performance monitoring system better aligned to a new council structure.
The City Council needs to ensure the correct information and data is presented and managed by the appropriate committee, following a recent move away from a cabinet-style leadership to a committee structure of governance.
Ideagens Pentana Performance software will ensure that operational monitoring and reporting will be replicated electronically, providing the council with a single picture of performance.
David Sutton, Deputy Director Commissioning and Transformation at Worcester City Council, said: The Pentana Performance software will align structurally to the way we are set up as an organisation.
The software will integrate risks and performance, ensuring that they are being managed and monitored in one system rather than three or four.
Having listened to the presentation at ShareSoc this week it is clear that IDEA is on a mission to become a large respected British software company of
Which there are precious few).The aim is to continue growing at 25% for the medium term compoumd. If they can achieve that then they will double in 3 years and much more in 10. There are good reasonsn why this is eminently possible . Recurring revenue is heading the towards 75% target , there are many verticals that they still do not service and they have ,most importantly , a very ambitious leader and team behind him . I strongly believe you would be a fool to bet against them achieving this goal . Whether they are up or down 10% in the short term is ,frankly , short sighted as the medium term picture is so exciting . We will look back in 3 years and wonder why we didnt put a large chunk of our capital into IDEA
Ps Im in large .
Share that view in regard to short term price movements .However , no debts , cash pile growing nicely and envious client list there has to be a t/o risk premium with a weak £ . So I am holding till full results and full trading information.
I took my position down by 50% post the results. I'm still very happy if it goes higher but post the results and in the absence of an acquisition, I don't see any short term upwards momentum. My suspicion is the shares will remain in this 80-90 channel for the time being - probably drifting down towards the bottom end over the coming weeks - and there will need to be bigger news for them to break out above this. I'll look to re-enter if we get back to 80
"Certainly, the FTSE 100 may be relatively high at the present time, but this stock could offer high growth at a reasonable price. As such, it could be worth buying today ahead of potentially FTSE 100-beating performance.
The company in question is Information Management Software provider Ideagen (LSE: IDEA). It reported an upbeat trading update for the first six months of its financial year on Tuesday. The companys performance was strong during the period, and it remains on target to deliver revenue and adjusted EBITDA (earnings before interest, tax, depreciation and amortisation) which are significantly ahead of the same period from the prior year.
In fact, the business is expected to post an underlying organic revenue growth rate of around 12% for the period. It is also on track to meet expectations for the full year to 30 April 2018. Encouragingly, cash generation in the first half of the year was strong, with the companys balance sheet having a £5.9m cash position as well as no debt. This reduces its overall risk and provides it with an improved risk/reward ratio for the long run.
Ideagen is forecast to post a rise in its bottom line of 26% in the current year, followed by further growth of 10% next year. Despite such an impressive growth outlook, the companys shares trade on a price-to-earnings growth (PEG) ratio of just 0.8. This suggests that they offer a wide margin of safety and that more upside potential is on offer after their 31% gain since the start of the year."
There is another £2.1m to pay on IPI also, the bulk of which is in December, so will be in the FY numbers. After that they are pretty much free of commitments so without an acquisition cash will start piling up. In any case they have no debt and have shown the ease at which they can raise £10m at the drop of a hat through a share placing, so they could easily afford to spend £15-20m on acquisitions.
If PleaseTech performs - remember its revenues are primarily from the U.S so the decline in GBP should provide an additional boost - I see no reason why we aren't on track for £10m of adj EBITDA this year (£8m IDEA existing businesses + £2m PT), which I think translates through to about 4.5p of adjusted EPS, a little ahead of the 4.2p I think Finncap have for them.
It's all a bit speculative to try to predict the numbers from where a private investor sits but the bottom line is organic growth remains constant at 10-15% a year, the b/s is in a good condition and over the long-term there is lots of upside for those who are prepared to be patient
Yep, all seems nicely on track. Its always hard to read through from net cash generation to EBITDA in these updates because there are always slugs of deferred consideration on acquisitions to pay, so the cash balance looks lower than you might expect. In this period for example they would have paid £2m for PleaseTech. Lets see if Finncap or anyone else can come up with anything intelligent! Given its my biggest holding of any stock, I am certainly glad to see the shares back towards 90p!
"Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, today provides an update on trading for the six months ended 31 October 2017.
The Board is pleased to report that trading has remained strong in the first half of the financial year and expects to report revenue and adjusted EBITDA* significantly ahead of the same period last year with an underlying organic revenue growth of approximately 12%. The Company continues to trade in line with market expectations for the full year to 30 April 2018.
Cash generation in the period was strong and the Company maintains a robust balance sheet with no debt. The cash balance at the period end was £5.9 million (30 April 2017: £4.8 million).
David Hornsby, Chief Executive Officer of Ideagen, commented: "I am pleased to report yet another strong start to Ideagen's financial year. Our core markets are strong and underpin the demand we have seen this half. Cash generation has been excellent and the Group has seen further growth in its recurring revenues and repeat business.
The market opportunity remains large and long term and given the Group's position as a leader in the Governance, Risk and Compliance market, the Board is optimistic about the Group's continued growth prospects."
It would be great to break out of this modestly downwards sloping channel we have been in since the summer highs....above 90 is the rough level we need to break through, right where we are now in fact.....a close in the 93, 94 area would suggest to me we are quickly going to 100-110
Looking forward to knock-out numbers this week coming....
Inspiration Healthcare Group plc adopt Ideagen Q-Pulse for compliance & process management
18 October 2017
Inspiration Healthcare Group, a global supplier of medical technology for critical care, operating theatre and home healthcare applications, is adopting software from Ideagen to enhance regulatory compliance and key operational processes.
Ideagen Q-Pulse, Ideagens flagship quality management software, will help the company maintain high levels of compliance to a number of regulatory bodies such as ISO 13485:2016, FDA 21 CFR part 820 and European Medical Device standards.
Inspiration Healthcare manufactures and distributes its products to over 50 countries globally and will also adopt Q-Pulse for operational process management, particularly in relation to Design File History management a key requirement for medical device manufacturers.
Simon Travers, Head of Quality Assurance and Regulatory Affairs at Inspiration Healthcare, said: For both compliance and operational reasons it was imperative that we brought Q-Pulse in. The software will make it easier for us to comply with several standards and satisfy the strict requirements of those notified bodies.
Although regulatory compliance was the main reason for adopting the software, there were many process reasons also. There will be document control and review, audit, corrective and preventive action benefits not to mention Q-Pulse becoming a central repository for the management and review of suppliers, assets and staff competency management.
Inspiration Healthcare provides high-quality innovative products to patients and caregivers around the world that help to improve patient outcomes and efficiencies of healthcare organisations. Its products cover non-invasive respiratory management, thermoregulation, and patient warming for newborn babies through to adults in intensive care and the operating theatre.
The companys distribution business supplies solutions to support specialised surgical procedures and infusions therapies.
A particular area of focus for the new Q-Pulse system will be in the management of the companys Design File History documentation. Simon explained: Within the medical device industry, organisations such as ours are required to maintain a Design History File basically a complete story of how a product is created for every product that is designed and taken to market.
We will be using the standard change request functionality within Q-Pulse to conduct periodic reviews every 12 months of our DFH documentation, ensuring we are on top of them. Q-Pulse will automatically remind stakeholders that a review is upcoming or overdue.
Ideagen, a UK-based software company which has a global footprint, provides software and services to more than 400 healthcare organisations globally, including 75% of the UK NHS. Other clients in this sector include Nuffield Health, Great Ormond Street Hospital, Spire Healthcare and El Camino Hospital."
"BDO UK extends the use of Ideagen's Pentana Audit software
30 October 2017
Following its success in the UK, BDO South Africa's Risk Advisory Services (RAS) division will be rolling out Pentana Audit
BDO UK, part of the international accountancy and business advisory firm, is to extend its use of Ideagen's internal auditing software to its South African member firm following its success in the United Kingdom.
Pentana Audit will be rolled out across BDO South Africa's Risk Advisory Service (RAS) offering to help with internal audit services for its clients.
BDO South Africa's RAS division provides outsourced internal audit services for organisations operating mainly within the mining sector. In addition to executing projects in South Africa, this division has a client bas
"Ideagen to offer HIPAA-compliant cloud hosted audit automation solution
09 October 2017
Ideagen, a global leader in providing regulatory and compliance management software solutions, has announced that it will meet the needs of its HIPAA regulated customers with the latest Pentana Audit hosted offering.
HIPAA the Health Insurance Portability and Accountability Act sets the standard for protecting sensitive patient health data in the United States.
Companies that deal with protected health information (PHI) must ensure that all the required physical, network and process security measures are in place and followed.
Jack Leech, Ideagens Product Ambassador for Pentana, said: Where US-based customers are in the healthcare industry, they will need assurance that Pentana is HIPAA compliant in relation to any electronic protected health information (ePHI).
We are delighted to confirm that from today, Ideagen Pentana can now be supplied as a HIPAA-compliant offering, helping organisations achieve and maintain compliance with requirements in relation to ePHI data.....
.......Pentana is Ideagens flagship audit automation software solution. The software is trusted and used by over 450 clients worldwide including Heineken, BBVA, BDO, Standard Life and the European Central Bank."
"Ideagen launch enhanced PatientFirst software following Emergency Care Data Set (ECDS) revamp
06 October 2017
Ideagen, developers of healthcare software designed to modernise clinical workflows and analysis, has launched an enhanced version of its PatientFirst product following an overhaul of emergency care management in England.
The PatientFirst update will allow NHS England organisations to capture in-depth patient and emergency care data to improve operational awareness for senior management and enhance the patient experience throughout A&E.
The update comes following the launch of the new Emergency Care Data Set (ECDS) on Sunday, October 1st. The ECDS will replace the current but dated A&E Commissioning Data Set (CDS).
Paul Kenyon, Senior Business Analyst at Ideagen, said: The launch of the new ECDS will be a major overhaul for NHS England organisations who have been used to capturing and reporting on data in the same way for over 30 years.
Emergency care has moved on, and so has the needs of patients. The current CDS struggles to handle modern demographics going through the emergency care process and the structure and landscape of A&E has changed significantly with the introduction of specialised units, such as paediatric and minor injury units for example.
Paul added: Ideagens PatientFirst has met this proposed change head on and will make it easier for organisations to meet the requirements of the new ECDS. It brings with it more granularity in terms of reporting and will make it easier to track a patients journey through the department.
For management, they will be able to analyse data quicker and easier than before and assess the performance of their department over a set period of time. For example, this could help with advanced bed management as they will be able to see what periods they expect a higher footfall passing through the A&E department.
Healthcare organisations will be required to report to the ECDS on a weekly basis with a cut-off date of March 2019 to be fully up and running in terms of quality and frequency of data capture.
NHS England has set a five-phased approach to be ready for the 2019 deadline. However, PatientFirst has been launched specifically to help organisations meet the ECDS demands fully from October 1st.
Paul added: Using PatientFirst, organisations will be able to meet the demands of the ECDS immediately, almost two years ahead of the proposed deadline."
Important message from the Financial Conduct Authority:
Posting inside information that is not public knowledge, or information that is false or misleading, may constitute market abuse.
This could lead to an unlimited fine and up to seven years in prison.
If you have any information, concerns or queries about market abuse, click here.
The content of the messages posted represents the opinions of the author, and does not represent the opinions of Interactive Investor Trading Limited or its affiliates and has not been approved or issued by Interactive Investor Trading Limited.
You should be aware that the other participants of the above discussion group are strangers to you and may make statements which may be misleading, deceptive or wrong.
Please remember that the value of investments or income from them may go down as well as up and that the past performance of an investment is not a guide to its performance in the future.
The discussion boards on this site are intended to be an information sharing forum and is not intended to address your particular requirements.
Whilst information provided on them can help with your investment research you need to consider carefully whether you should make (or refraining from making) investment or other decisions based on what you see without doing further research on investments you are interested in.
Participating in this forum cannot be a substitute for obtaining advice from an appropriate expert independent adviser who takes into account your circumstances and specific investment needs in selected investments that are appropriate for you.